Your browser doesn't support javascript.
loading
Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
González-Martín, A; Harter, P; Leary, A; Lorusso, D; Miller, R E; Pothuri, B; Ray-Coquard, I; Tan, D S P; Bellet, E; Oaknin, A; Ledermann, J A.
  • González-Martín A; Department of Medical Oncology and Program in Solid Tumors Cima-Universidad de Navarra, Cancer Center Clínica Universidad de Navarra, Madrid and Pamplona, Spain.
  • Harter P; Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany.
  • Leary A; Department of Medical Oncology, Gustave Roussy Cancer Center, INSERM U981, Université Paris-Saclay, Paris, France.
  • Lorusso D; Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome; Department of Woman, Child and Public Health, Catholic University of the Sacred Heart, Rome, Italy.
  • Miller RE; Department of Medical Oncology, University College Hospital, London; Department of Medical Oncology, St Bartholomew's Hospital, London, UK.
  • Pothuri B; Department of Obstetrics and Gynecology, Perlmutter Cancer Center, NYU Langone Health, New York University School of Medicine, New York, USA.
  • Ray-Coquard I; Department of Medical Oncology, Centre Leon Bernard and Université Claude Bernard Lyon I, Lyon, France.
  • Tan DSP; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; National University of Singapore (NUS) Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Cancer Science Institute, National Univers
  • Bellet E; ACTO-Alleanza contro il Tumore Ovarico, Milan, Italy.
  • Oaknin A; Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Ledermann JA; Department of Oncology, UCL Cancer Institute, University College London, London, UK.
Ann Oncol ; 34(10): 833-848, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37597580

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline Idioma: En Año: 2023 Tipo del documento: Article